ID: ALA2238397

Max Phase: Preclinical

Molecular Formula: C20H18ClNO3S

Molecular Weight: 387.89

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(S(=O)(=O)Nc2ccc(OCc3cccc(Cl)c3)cc2)cc1

Standard InChI:  InChI=1S/C20H18ClNO3S/c1-15-5-11-20(12-6-15)26(23,24)22-18-7-9-19(10-8-18)25-14-16-3-2-4-17(21)13-16/h2-13,22H,14H2,1H3

Standard InChI Key:  KYQNAIYUJORBSK-UHFFFAOYSA-N

Associated Targets(non-human)

Cholesteryl ester transfer protein 233 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 387.89Molecular Weight (Monoisotopic): 387.0696AlogP: 5.03#Rotatable Bonds: 6
Polar Surface Area: 55.40Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.24CX Basic pKa: CX LogP: 5.15CX LogD: 5.09
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.65Np Likeness Score: -1.70

References

1. Abu Khalaf R, Abu Sheikha G, Al-Shaer M, Albadawi G, Taha M.  (2012)  Design, synthesis, and biological evaluation of sulfonic acid ester and benzenesulfonamide derivatives as potential CETP inhibitors,  21  (11): [10.1007/s00044-011-9917-5]

Source